| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/10/2003 | US20030069278 Heterocyclyloxy-, -thioxy- and -aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 04/10/2003 | US20030069272 Prevent joint stiffness; adjust concentration of synovial fluid |
| 04/10/2003 | US20030069270 Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxImic acid derivative |
| 04/10/2003 | US20030069260 1-alkyl or 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors |
| 04/10/2003 | US20030069256 Use of isogenic human cancer cells for high-throughput screening and drug discovery |
| 04/10/2003 | US20030069255 Pharmaceutical compositions for the coordinated delivery of NSAIDs |
| 04/10/2003 | US20030069254 New arylsulfonyl derivatives with 5-HT6 receptor affinity |
| 04/10/2003 | US20030069249 Analgesics; central nervous system disorders |
| 04/10/2003 | US20030069248 Antiinflammatory agents; controlling cell cycle |
| 04/10/2003 | US20030069246 Central nervous system disorders; psychological disorders; cardiovascular disorders |
| 04/10/2003 | US20030069243 Novel substituted imidazole compounds |
| 04/10/2003 | US20030069241 Analgesics; central nervous system disorders; gastrointestinal disorder; therapy for drug abruse ; antiinflammatory agents |
| 04/10/2003 | US20030069238 Anticancer agents; immunology diseases; antiallergens; antiinflammatory agents |
| 04/10/2003 | US20030069233 Central nervous system disorders; psychological disorders; Alzheimer's disease |
| 04/10/2003 | US20030069229 Methods of inhibiting metastases |
| 04/10/2003 | US20030069228 Capase inhibitors; antiinflammatory agents |
| 04/10/2003 | US20030069226 Benzothiazole or benzothiazine derivatives of dipyrido(3,2b:2',3'-e)(1,4-diazepin-6-one |
| 04/10/2003 | US20030069224 Non-nucleoside reverse transcriptase inhibitors |
| 04/10/2003 | US20030069223 Peptidyl deformylase inhibitors used for inhibiting bacteria or preventing bacterial contamination of a cell culture medium |
| 04/10/2003 | US20030069221 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions |
| 04/10/2003 | US20030069210 Especially imidazolyl- or 1,2,4-triazolyl- pyrimidine derivatives |
| 04/10/2003 | US20030069205 Anionic polymers including dermatan sulfate, chondroitin sulfate, keratan sulfate, heparan sulfate, heparin, dextran sulfate, pentosan polysulfate, hyaluronic acid and alginate. |
| 04/10/2003 | US20030069201 Methods of using BCL-2 for the therapeutic treatment and prevention of diseases |
| 04/10/2003 | US20030069186 Chimeric natriuretic peptides |
| 04/10/2003 | US20030069183 Lyophilized HGF preparations |
| 04/10/2003 | US20030069169 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-AMP associated disorders |
| 04/10/2003 | US20030068366 Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
| 04/10/2003 | US20030068336 Purified capsular polysaccharides from Neisseria meningitidis serogroups are activated and attached to a carriers protein |
| 04/10/2003 | US20030068333 Cocktail of >/= 4 different plasmid DNAs encoding corresponding respiratory syncytial virus antigens, coacervated with chitosan to formulate nanospheres |
| 04/10/2003 | US20030068280 Treatment of respiratory diseases |
| 04/10/2003 | US20030068278 Administering fine powder of active material; measured aerosol |
| 04/10/2003 | US20030066524 Closure-cap and container as a two-chamber cartridge for nebulisers for producing aerosols and active substance formulations, suitable for storage |
| 04/10/2003 | CA2466020A1 Rsv gene expression vaccine |
| 04/10/2003 | CA2462796A1 Gene regulatory peptides |
| 04/10/2003 | CA2462647A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | CA2462601A1 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | CA2462443A1 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
| 04/10/2003 | CA2462427A1 Treatment of hepatitis b virus infection with human monoclonal antibodies |
| 04/10/2003 | CA2462425A1 Therapeutically useful triethyleneglycol cholesteryl oligonucleotides |
| 04/10/2003 | CA2462424A1 A novel g protein-coupled receptor, gave 10 |
| 04/10/2003 | CA2462419A1 N-heterocyclyl hydrazides as neurotrophic agents |
| 04/10/2003 | CA2462305A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | CA2462140A1 Ferroportin-1 mutant |
| 04/10/2003 | CA2462110E Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 04/10/2003 | CA2462030A1 3-`hydroxy-(-4-trifluoromethylphenyl)-methyl-7-spirocyclobutyl-5,6,7,8-tetrahydroquinolin-5-ol derivatives and the use of the same as cholesterol ester transfer protein (cetp) inhibitors |
| 04/10/2003 | CA2461998A1 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 04/10/2003 | CA2461905A1 Combined compositions and methods for tumor vasculature coagulation and treatment |
| 04/10/2003 | CA2461877A1 Method of treatment using ligand-immunogen conjugates |
| 04/10/2003 | CA2461715A1 Proliferation and differentiation of stem cells using extracellular matrix and other molecules |
| 04/10/2003 | CA2461670A1 Indole derivatives as cox ii inhibitors |
| 04/10/2003 | CA2461596A1 Method for treating hepatitis c virus infection in treatment failure patients |
| 04/10/2003 | CA2461292A1 Apo-2 ligand variants and uses thereof |
| 04/10/2003 | CA2461034A1 Tetrahydroisochinolines, their production and the use thereof as analgesics |
| 04/10/2003 | CA2460917A1 Human tissue factor antibodies |
| 04/10/2003 | CA2460916A1 Methods and compositions for modulating interleukin-21 receptor activity |
| 04/10/2003 | CA2460909A1 N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl) -n-phenylamines as antiproliferative compounds |
| 04/10/2003 | CA2460594A1 Mch receptor antagonists |
| 04/10/2003 | CA2460261A1 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer |
| 04/10/2003 | CA2460257A1 Methods for diagnosing and treating heart disease |
| 04/10/2003 | CA2459825A1 Compounds useful as reversible inhibitors of cysteine proteases |
| 04/10/2003 | CA2458343A1 Pharmaceutical combinations of pde-v inhibitors and other agents |
| 04/10/2003 | CA2457647A1 Benzimidazolidinone derivatives as muscarinic agents |
| 04/10/2003 | CA2455225A1 Novel proteins and nucleic acids encoding same |
| 04/10/2003 | CA2430328A1 Receptor antagonist |
| 04/09/2003 | EP1300468A2 TRNA synthetase |
| 04/09/2003 | EP1300424A1 Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use |
| 04/09/2003 | EP1300418A1 Gene regulation by oligopeptides |
| 04/09/2003 | EP1300412A1 Hyaluronic acid oligosaccharide fractions and drugs containing the same |
| 04/09/2003 | EP1300407A1 Carbamates derived from arylalkylamines |
| 04/09/2003 | EP1300396A1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
| 04/09/2003 | EP1300395A1 4-substituted piperidine compound |
| 04/09/2003 | EP1300146A1 Pharmaceutical composition for the treatment of animal mammary tumors |
| 04/09/2003 | EP1300141A1 Medical composition kit for treating lesioned abnormal tissue |
| 04/09/2003 | EP1300138A2 Agents effective against hyperreactive and hypoactive deficient skin conditions as well as manifest dermatitis |
| 04/09/2003 | EP1300084A2 Composition for the treatment of chronic venous insufficiencies comprising an extract of red vine leaves |
| 04/09/2003 | EP1299560A2 Identification and modulation of t helper-1 and t helper-2 cells |
| 04/09/2003 | EP1299548A1 Novel therapeutic molecular variants and uses thereof |
| 04/09/2003 | EP1299545A2 Drug metabolizing enzymes |
| 04/09/2003 | EP1299542A2 Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof |
| 04/09/2003 | EP1299541A2 Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses |
| 04/09/2003 | EP1299534A2 Grf2-binding proteins and applications thereof |
| 04/09/2003 | EP1299529A2 Conserved diaphanous-related formin autoregulatory domain (dad) |
| 04/09/2003 | EP1299430A2 Process for preparing benzoxazin-4-one polymer conjugates |
| 04/09/2003 | EP1299421A2 Antibodies to human mcp-1 |
| 04/09/2003 | EP1299419A2 Bispecific immunoglobulin-like antigen binding proteins and method of production |
| 04/09/2003 | EP1299417A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 04/09/2003 | EP1299412A2 Protein modification and maintenance molecules |
| 04/09/2003 | EP1299410A2 GFR alpha1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 04/09/2003 | EP1299409A2 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 04/09/2003 | EP1299395A1 Oxazinoquinolones useful for the treatment of viral infections |
| 04/09/2003 | EP1299392A2 Glucocortiocoid-selective antiinflammatory agents |
| 04/09/2003 | EP1299387A1 Heterocycle carboxamides as antiviral agents |
| 04/09/2003 | EP1299386A1 Pyrroloquinolones as antiviral agents |
| 04/09/2003 | EP1299385A2 Fused cyclic modulators of nuclear hormone receptor function |
| 04/09/2003 | EP1299384A1 Indole derivatives useful for the treatment of cns disorders |
| 04/09/2003 | EP1299383A1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 04/09/2003 | EP1299381A1 Substituted quinazoline derivatives and their use as inhibitors |
| 04/09/2003 | EP1299380A1 Indole derivatives useful for the treatment of cns disorders |
| 04/09/2003 | EP1299378A1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 04/09/2003 | EP1299377A2 Spla2 inhibitors |